Filter results
Type
Audience
Last updated
Topics
-
Life Saving Drugs Program – Hereditary tyrosinaemia (type 1) – Initial application
Resources › Publications27 September 2024 - Treating physicians use this application form to apply for a patient to access LSDP medication for hereditary tyrosinaemia (type 1) for the first time, or after a break.
-
Life Saving Drugs Program – Mucopolysaccharidosis type IVA (MPS IVA) – Guidelines
Resources › Publications27 September 2024 - These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for mucopolysaccharidosis type IVA (MPS IVA) under the Life Saving Drugs Program.
-
Life Saving Drugs Program – Mucopolysaccharidosis type II (MPS II) – Guidelines
Resources › Publications27 September 2024 - These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for mucopolysaccharidosis type II (MPS II) under the Life Saving Drugs Program.
-
Life Saving Drugs Program – Mucopolysaccharidosis type I (MPS I) – Guidelines
Resources › Publications27 September 2024 - These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for mucopolysaccharidosis type I (MPS I) under the Life Saving Drugs Program.
-
Life Saving Drugs Program – Mucopolysaccharidosis type VI (MPS VI) – Guidelines
Resources › Publications27 September 2024 - These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for mucopolysaccharidosis type VI (MPS VI) under the Life Saving Drugs Program.
-
ATAGI recommendations on use of the Moderna and Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccines
News and media20 November 2023 - Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of XBB 1.5 COVID-19 vaccines.
-
Marketing in Australia of Infant Formulas (MAIF) complaint outcomes list for previous financial years
Resources › Publications13 December 2024 - This document contains a summary of Marketing in Australia of Infant Formulas (MAIF) complaint outcomes from financial year 2023–24.
-
Emergency Response Plan for Communicable Diseases of National Significance (CD Plan)
Resources › Publications1 September 2016 - This plan outlines what happens when an outbreak of a communicable disease becomes a national emergency. It is endorsed by the Australian Health Protection Principal Committee (AHPPC).
-
What they are and how they can help you – Easy Read
Find your nearest Medicare Urgent Care Clinic › Resources8 January 2024 - This fact sheet tells you about the Medicare Urgent Care Clinics, what they are and how they can help you.
-
Got a slippery question about what’s on your budoo? – True or Gammon – Social animation
Make STI testing your Beforeplay › Resources on sexually transmissible infections3 May 2024 - A 15-second video animation to share on your social channels to encourage yarning with Aboriginal and Torres Strait Islander people.